ModelOp Center
AI governance platform positioned for healthcare, payer, pharmaceutical, and biotech teams that need visibility, lifecycle controls, and risk-based compliance across AI initiatives.
Last updated: June 5, 2026
Back to directoryHealthcare-focused AI governance and enforcement platform positioned around PHI redaction, BAA-native routing, policy controls, registry coverage, and signed audit evidence.
Healthcare teams that need a control layer around clinician copilots, payer AI workflows, or health-tech SaaS features before prompts, PHI, and model outputs reach approved AI providers.
Compare within workflow: AI governance and monitoring · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating ShadowIQ for Healthcare as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as an AI governance, enforcement, and evidence layer; each downstream clinical, payer, or SaaS AI use case still needs intended-use classification, HTI-1 or FDA SaMD review when applicable, and accountable human oversight. |
|---|---|
| Privacy | Review BAA availability, DPA terms, PHI detection limits, redaction or tokenization behavior, subprocessor/model routing, tenant keys, retention periods, evidence exports, and access controls. |
| Evidence | Validate claims about zero PHI egress, signed decision receipts, policy enforcement, registry completeness, and FDA lifecycle artifacts against a representative local workload before production use. |
| Workflow | Best governed as an AI traffic-control and audit-evidence layer with change control for policies, approved model routes, exception queues, incident review, and periodic governance committee reporting. |
ShadowIQ describes its healthcare offering as a HIPAA-grade AI governance platform with inline PHI redaction, BAA-aware routing, HITRUST alignment, FDA SaMD controls, policy enforcement, a registry/evidence surface, and cryptographically signed audit trails for healthcare AI decisions; its privacy and DPA pages should be reviewed before sending PHI or regulated evidence through the service.
Not for: Replacing clinical validation, legal review, medical-device submissions, or local approval for the underlying AI products being routed and monitored.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.